Cancer Chemotherapy Agents Flashcards
Akylating Agents
Non cell cycle specific
Where do alkylating agents originate from
sulfur and nitrogen mustard warfare agents
Later generation mustard agents
Akylating Agents
Non cell cycle specific
- cyclophosphamide
- ifosfamide generate
- BCNU (carmustine
- CCNU (lomustine)
- thiotepa
Cyclophosphamide
Akylating Agents
Non cell cycle specific
- Later generation mustard agent
- generates acrolein, which is toxic to the bladder
Ifosfamide
Akylating Agents
Non cell cycle specific
- later generation mustard agents
- generate acrolein, which is toxic to the bladder
BCNU
carmustine
Akylating Agents
Non cell cycle specific
Later generation mustard agent
CCNU
lomustine
Akylating Agents
Non cell cycle specific
later generation mustard agent
All mustard agents
- prodrugs
- – need metabolic activation
- orally active
Thiotepa
Akylating Agents
Non cell cycle specific
- lipophilic
- – penetrates well into brain and can kill metastases of non-neuronal neoplasms in the brain
Hydrazines
alylating agent (non cell cycle specific) - prodrugs
Procarbazine
hydrazine (alkylating agent, non cell cycle specific)
Dacarbazine
hydrazine (alkylating agent, non cell cycle specific)
Temozolomide
hydrazine (alkylating agent, non cell cycle specific)
- orally active
- penetrates brain blood barrier
- useful for gliomas
Alkylating Agents Mechanism of Action
- non cell cycle specific
- highly reactive
- – alkylate protein, RNA, DNA and cause strand breaks, crosslinks and mismatches, disrupting DNA synthesis/replication
Alkylating Agents Adverse Effects
- classical - nausea, allopecia, myelosuppresion/immunosuppression
Akylating Agents
Resistance Mechanisms
- increased glutathione conjugation
- increased glutathione synthesis
- increased DNA repair
- decrease cellular update
- increased cellular efflux